Neos Therapeutics

1 stories about Neos Therapeutics
מטה טבע פתח תקווה

Teva Reaches Confidential Patent Settlement with Neos

27.12.18|CTech
The agreement will enable Teva to manufacture and sell a generic version of Neos’ ADHD drug Cotempla as of 2026
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1